Month: September 2020

Single Phase 3 trial to be conducted to support an NDA filing of AXS-12 in the treatment of narcolepsy; trial initiation anticipated 1Q 2021Extensive patient safety database, previously obtained through Pfizer exclusive license, to support NDA filingExtensive array of completed nonclinical studies sufficient to support NDA filingCompany to host conference call today at 8:00 AM EasternNEW YORK, Sept. 21, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that the development plan for AXS-12 for the treatment of narcolepsy has been expedited following a Breakthrough Therapy meeting with the U.S. Food and Drug Administration (FDA). AXS-12 is a novel, oral, highly selective and potent norepinephrine...

LATHAM, N.Y., Sept. 21, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of clean hydrogen and zero-emission fuel cell solutions for the power, energy, and transportation industries, will host its second annual Plug Symposium on Thursday, September 24, 2020.The event presents an opportunity for engaging dialogue on advancing sustainable solutions for an electrified world. The program features a deep dive into the state of the global green hydrogen economy. Alongside Plug Power’s executive leadership, the symposium brings together an impressive roster of speakers from across the industry and stakeholder groups. These experts will provide their perspectives on how the hydrogen and fuel cell industry is adapting to today’s dynamic environment of growth. The speakers will also share their insights on key micro...

AGOURA HILLS, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — Mateon Therapeutics “Mateon” (OTC.QB: MATN), a leading developer of TGF-β therapeutics for oncology and COVID-19, announced today that on September 21, 2020, Dr. Vuong Trieu, CEO of Mateon, will be presenting as Webinar “Trabedersen-Drug Development using phosphorothioate antisense platform” at Pharma Forum 2020/ Pharmacology and Toxicology/September 21, 2020. Of significant is the finding that cytokine levels of clinical plasma samples of 12 pancreatic cancer patients of the P001 study of OT-101 in advanced solid tumor patients were measured using the ImmunoSignal cytokine storm assay developed by Eurofins. Nine patients with elevated IL-6 were examined further. More than 50% of these patients (6 of 9) exhibited significant reduction in IL-6 level following 1st cycle of dosing...

SAN CLEMENTE, CA, Sept. 21, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (GWHP) announces it had submitted an Emergency Use Authorization (EUA) Application Submission Number: PEUA201789 Acknowledgement Letter date 09/14/2020: for the Global Antigen CoViD19 SARS2 Rapid Test as mentioned in the 8K filing dated September 15th, 2020.Since Global’s antigen tests are lateral flow and are a simple test similar to Nasal Influenza Test, Global is looking forward to continuing with the submission that was filed on September 14, 2020, and join the fight against CoViD19 SARS.HOW IT WORKS:A healthcare provider swabs the patient’s nose and twirls that sample on a test card with a testing reagent added. After waiting 10-15 minutes, the healthcare provider reads the results directly from the testing card. One...

BERKELEY HEIGHTS, N.J., Sept. 21, 2020 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced that an abstract highlighting clinical data with Cyclacel’s CDK2/9 inhibitor fadraciclib has been selected for an oral presentation at the 32nd EORTC-NCI-AACR (ENA) Symposium 2020 being held virtually on October 24 – 25, 2020. The data is from an ongoing Phase 1 study of fadraciclib as a single agent in patients with advanced solid tumors.Details for the presentations are as follows:Title: Phase 1 safety, pharmacokinetic and pharmacodynamic study of fadraciclib (CYC065), a cyclin dependent kinase inhibitor, in patients with advanced cancers (NCT02552953)Session Title: Late Breaking...

Orphazyme A/SCompany announcement                                                                                       No. 52/2020                                                                                                          Company Registration No. 32266355Orphazyme A/S has today commenced an initial public offering of American Depositary Shares on the Nasdaq Global Market (“Nasdaq”) in the United States under the symbol “ORPH”, filed a preliminary prospectus relating to the global offering and commenced a concurrent private placement of ordinary shares in EuropeThe proposed global offering of up to 7,616,146 new ordinary shares consists of an initial public offering of ordinary shares in the form of ADSs offered in the U.S. offering and a concurrent private placement of ordinary shares offered in a European private...

NEWPORT BEACH, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — DPW Holdings, Inc. (NYSE American: DPW) a diversified holding company (“DPW,” or the “Company”), announced today that its subsidiary, It’sLikeFashion.com, Inc. (“It’sLikeFashion”) https://www.ItsLikeFashion.com, a membership-only Ecommerce business, has successfully completed beta testing of its online platform. The Company stated it anticipates reporting revenue from It’sLikeFashion in the fourth quarter of 2020.ItsLikeFashion.com offers household brand name and luxury items ranging from apparel, bags, purses, shoes and accessories, to linens, bedding and similar items at prices discounted up to 90% off retail prices. Members will be able to access a variety of luxury and brand name items directly through the website, https://www.ItsLikeFashion.com, or through their favorite...

To Nasdaq Copenhagen A/S                                                               21 st   September 2020                                                                                                             Announcement no. 95/2020The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 24th, 2020.Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.comYours sincerely,Jyske Realkredit A/Swww.jyskerealkredit.comPlease observe that the Danish version of this announcement prevails.AttachmentDK0009404451...

Til Nasdaq Copenhagen A/S                                                                                       21. september 2020                                                                                                                                                 Meddelelse nr. 95/2020 Jyske Realkredit åbner den 23. september 2020 ny særligt dækkede obligation (SDO). Med denne meddelelse følger de endelige vilkår for obligationerne.Det samlede prospekt for obligationerne består af vedlagte endelige vilkår og det tidligere offentliggjorte ”Basisprospekt for udstedelse af Særligt Dækkede Obligationer (SDO), Realkreditobligationer (RO) og obligationer i medfør af § 15 i lov om realkreditlån og realkreditobligationer m.v. (§ 15 Obligationer)”, dateret 24. februar 2020.Jyske Realkredits basisprospekt er tilgængeligt på Jyske Realkredits...

NEW WESTMINSTER, BC, Sept. 21, 2020 (GLOBE NEWSWIRE) — DigitalTown, Inc. (OTC: DGTW) (the “Company”) announces that the Company has filed for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Minnesota, St. Paul Division, paving the way for business continuity, profitability and sustained growth in shareholder value.Following the announcement of a new management team in May 2019, DigitalTown began making substantial progress on their commitment of cleaning up the Company’s balance sheet and exploring opportunities that would bring value to the Company’s shareholders. DigitalTown was successful in converting over $2 million of debt into stock and structuring a go-forward plan with appropriate financing measures. The plan’s execution was conditional on negotiating a satisfactory...